πŸ‡ΊπŸ‡Έ FDA
Patent

US 7179794

Multivalent macrolide antibiotics

granted A61KA61K31/00A61K47/54

Quick answer

US patent 7179794 (Multivalent macrolide antibiotics) held by Theravance, Inc. expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Feb 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/00, A61K47/54, A61K47/55, A61K47/552